Skip to main content

sulfatase modifying factor 1

The SUMF1 gene provides instructions for making an enzyme called formylglycine-generating enzyme (FGE). This enzyme is found in a cell structure called the endoplasmic reticulum, which is involved in protein processing and transport. The FGE enzyme modifies other enzymes called sulfatases, which aid in breaking down substances that contain chemical groups known as sulfates. These substances include a variety of sugars, fats, and hormones. Specifically, FGE converts a protein building block (amino acid) within sulfatases called cysteine into a molecule called C-alpha-formylglycine.

Video picks for Genes
Video library

Normal function

The SUMF1 gene provides instructions for making an enzyme called formylglycine-generating enzyme (FGE). This enzyme is found in a cell structure called the endoplasmic reticulum, which is involved in protein processing and transport. The FGE enzyme modifies other enzymes called sulfatases, which aid in breaking down substances that contain chemical groups known as sulfates. These substances include a variety of sugars, fats, and hormones. Specifically, FGE converts a protein building block (amino acid) within sulfatases called cysteine into a molecule called C-alpha-formylglycine.

Conditions referring to this gene or chromosome

Other names

AAPA3037

C-alpha-formylglycine-generating enzyme 1

FGE

FGly-generating enzyme

sulfatase-modifying factor 1

UNQ3037

Patient picks for Genes

Related patient information and medicines

Disease-modifying antirheumatic drugs

Patient information leaflet

Disease-modifying antirheumatic drugs

Disease-modifying antirheumatic drugs (DMARDs) are medicines that are normally prescribed as soon as rheumatoid arthritis (RA) is diagnosed, in order to reduce damage to the joints. Disease-modifying antirheumatic drugs (DMARDs) are a group of medicines that are used to ease the symptoms of rheumatoid arthritis (RA) Rheumatoid arthritis and reduce.

Reactive arthritis

Patient information leaflet

Reactive arthritis

... If symptoms continue for more than a few months, or if other treatments have not worked, you may be advised to take a disease-modifying medicine Disease-modifying antirheumatic drugs. These are sometimes called disease-modifying antirheumatic drugs (DMARDs). This aims to reduce the damaging effect on the joints. There are several - for.

Psoriatic arthritis

Patient information leaflet

Psoriatic arthritis

Psoriatic arthritis is a particular type of arthritis that develops in some people who also have psoriasis. Arthritis Arthritis means inflammation of the joints. They work by blocking the effects of chemicals involved in causing joint inflammation. Sulfasalazine Sulfasalazine and methotrexate Methotrexate are the most commonly used DMARDs for.

Rheumatoid arthritis

Patient information leaflet

Rheumatoid arthritis

Rheumatoid arthritis causes inflammation, pain, and swelling of joints. Rheumatoid arthritis treatment Standards of care you should expect The National Institute for Health and Care Excellence (NICE) has published quality standards on the standard of care that should be offered to every adult over 16 who has RA. ...Ds) Disease-modifyingDMARDs.

Primary sclerosing cholangitis

Patient information leaflet

Primary sclerosing cholangitis

Primary sclerosing cholangitis is an uncommon condition affecting the bile ducts and liver. Inflammation and scarring of the bile ducts can lead to liver damage and cirrhosis - a condition where normal liver tissue is replaced by scar tissue (fibrosis). Different treatments are available to control symptoms that may develop and also to manage ....

Juvenile idiopathic arthritis

Patient information leaflet

Juvenile idiopathic arthritis

So, juvenile idiopathic arthritis (JIA) is a condition in which this inflammation of one or more joints begins in children under the age of 16 years. ...e used to help reduce the effects of the disease Disease-modifyingDMARDs used for JIA include: Methotrexate Methotrexate Sulfasalazine Sulfasalazine Leflunomide Leflunomide tablets for arthritis.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 18 Aug 2020 | Latest version
  • 1 Jul 2014 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.